We receive funding from a variety of sources that recognize the value of our high-impact research.
Remi Adelaiye-Ogala, PhD
Posttranslational modifications of glucocorticoid receptor associated with drug resistance in prostate cancer. Remi Adelaiye-Ogala (Principal Investigator). NCI/NIH. 4/1/2024-5/1/2029.